Freshfields Bruckhaus Deringer has advised Novartis AG on the sale of its 36.5% stake in its consumer health joint venture with GlaxoSmithKline plc for US$13bn. The…
GlaxoSmithKline plc’s US$13bn acquisition of 36.5% stake in its consumer health joint venture with Novartis AG
![](https://globallegalchronicle.com/wp-content/uploads/2018/04/b66c94394f.jpeg)